Perspective Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Perspective Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q1 2024.
  • Perspective Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $166M.
  • Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $785K, a 2704% increase from 2022.
  • Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $28K, a 100% decline from 2021.
  • Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $64.7M, a 6407% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $166M +$166M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -$80K -$80K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $28K +$28K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2018 $7.49M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q3 2013 $3.28M -$20.6K -0.63% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q3 2012 $3.3M +$3.26M +8104% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q3 2011 $40.2K +$52.2K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q3 2010 -$11.9K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.